AstraZeneca's Covid-19 vaccine shows 76 per cent efficacy in updated US trial results

Following the doubts expressed by a top US-based health agency over the Covid-19 vaccine trial data, British-Swedish drugmaker AstraZeneca has shared the primary analysis of its vaccine with the most up-to-date data. It said that the COVID-19 vaccine is 76 per cent effective.

from IndiaTV World: Google News Feed https://ift.tt/3sp6b2O